As observed in our results, nausea could be the most common complication of GLP1-Ras therapeutic plans, after constipation, and abdominal pain [60]
[10] Combination of exercise and GLP-1 receptor agonist treatment reduces severity of metabolic syndrome, abdominal obesity, and inflammation: a randomized controlled trial | Cardiovascular Diabetology | Springer Nature Link
Koliaki, C
Zhang Q, Li Q, Liu S, Zheng H, Ji L, Yi N et al (2022) Glucagon-like peptide-1 receptor agonist attenuates diabetic neuropathic pain via inhibition of NOD-like receptor protein 3 inflammasome in brain microglia
Some providers recommend more frequent thyroid function testing when starting injectable GLP-1 medications in patients taking levothyroxine, particularly during the first few months of treatment and after significant weight loss
Dietary Recommendations for the Management of Gastrointestinal Symptoms in Patients Treated with GLP-1 Receptor Agonist